What drives many of us who work in the life science, medical device, pharmaceutical or biotechnology industries is making a difference to the lives of patients through what we do. One organization that embodies this philosophy is the Michael J. Fox Foundation.
Pieter Droppert recently interviewed Dr Todd Sherer, the foundation’s Chief Program Officer. In the first of a two part interview on Biotech Strategy Blog, Dr Sherer explained their approach to funding of Parkinson’s disease research.